SIREN : 522288174
BIOSOLVE - CHIMIE is a French company founded 16 years ago, specialized in the sector Recherche-développement en biotechnologie. Based in DIEUZE (57260), this company of category PME shows in 2024 a revenue of 16.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-08-01
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
Aucun signal de fragilité majeur : rentabilité positive et structure financière équilibrée.
In summary, BIOSOLVE - CHIMIE posts positive profitability over the latest financial year. Its financial structure is broadly in line with its sector.
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16 894 868 € | 17 978 253 € | 20 636 218 € | 20 075 009 € | 17 208 166 € | 18 134 053 € | 11 910 779 € | 8 770 386 € | 7 631 323 € |
| Net income | 874 849 € | 1 004 594 € | 1 472 069 € | 1 949 722 € | 869 891 € | 942 176 € | 330 899 € | 115 557 € | 340 014 € |
| EBITDA | 1 856 833 € | 1 857 297 € | 2 386 012 € | 3 089 227 € | 1 789 164 € | 1 728 778 € | 766 149 € | 413 459 € | 823 563 € |
| Net margin | 5.2% | 5.6% | 7.1% | 9.7% | 5.1% | 5.2% | 2.8% | 1.3% | 4.5% |
In 2024, BIOSOLVE - CHIMIE achieves revenue of 16.9 M€. Activity remains stable over the period (CAGR: -0.5%). Slight decline of -6% vs 2023. After deducting consumption (11.0 M€), gross margin stands at 5.9 M€, i.e. a rate of 35%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 1.9 M€, representing 11.0% of revenue. This ratio is more favorable than the sector median (-0.7%). Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 875 k€, i.e. 5.2% of revenue. This profit can be retained or distributed to shareholders.
16 894 868 €
5 871 886 €
1 856 833 €
1 074 036 €
874 849 €
11.0%
The debt ratio (= Financial debt / Equity x 100) stands at 43%. This ratio is slightly less favorable than the sector median (14.7%). Financial autonomy (= Equity / Total assets x 100) reaches 52%. This ratio is slightly less favorable than the sector median (53.9%). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 2.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 9.8% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This ratio is more favorable than the sector median (4.8%).
43.26%
51.79%
9.77%
2.1
37.6%
In 2024, the debt ratio of BIOSOLVE - CHIMIE (43.3%) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of BIOSOLVE - CHIMIE (51.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
The liquidity ratio (= Current assets / Current liabilities) stands at 3.87. This ratio is more favorable than the sector median (3.7). The interest coverage ratio (= EBIT / Interest expenses) is 3.2x. Financial charges are adequately covered by operations.
3.87
3.24
In 2024, the liquidity ratio of BIOSOLVE - CHIMIE (3.87) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 52 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 80 days. Favorable situation: supplier credit is longer than customer credit by 28 days. Inventory turnover is 55 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 126 days of revenue, i.e. 5.9 M€ to permanently finance. Between 2021 and 2024, WCR improved by 22 days of revenue, freeing up cash.
5 896 647 €
52 j
80 j
55 j
126 j
Indicative estimate only : the number of comparable transactions in this sector is limited (36 transactions). This range of 1 107 951€ to 10 691 056€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 36 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIOSOLVE - CHIMIE with other companies in the same sector:
Voir toutes les statistiques du secteur Recherche-développement en biotechnologie
Largest companies by revenue in the sector Recherche-développement en biotechnologie:
Largest companies by revenue in the department Moselle:
The revenue of BIOSOLVE - CHIMIE in 2024 is 16.9 M€.
Yes, BIOSOLVE - CHIMIE generated a net profit of 875 k€ in 2024.
The headquarters of BIOSOLVE - CHIMIE is located in DIEUZE (57260), in the department Moselle.
The tax return of BIOSOLVE - CHIMIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOSOLVE - CHIMIE operates in the sector Recherche-développement en biotechnologie (NAF code 72.11Z). See the 'Sector positioning' section above to compare the company with its competitors.